European equities traded in the US as American depositary receipts were little changed late Monday morning, edging 0.04% lower to 1,592.21 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and telecommunications company Nokia (NOK), which rose 5.6% and 2.8% respectively. They were followed by telecommunications company Ericsson (ERIC) and lender ING (ING), which were up 1.8% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which fell 6.1% and 2.8% respectively. They were followed by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma (ASND), which were down 2.7% and 2.4% respectively.

From the UK and Ireland, the gainers were led by tobacco company British American Tobacco (BTI) and insurance company Prudential (PUK), which advanced 2.7% and 1.6% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and alcoholic beverage company Diageo (DEO), which increased 1.5% and 1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which dropped 12.4% and 9.7% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and communications company WPP (WPP), which lost 7.4% and 4.4% respectively.